FindTrial
Sign In

Dynamic determination of serum MCP-1 and RANTES levels after intracerebral hemorrhage

Dynamic determination of serum MCP-1 and RANTES levels after intracerebral hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-12002132
Enrollment
Unknown
Registered
2012-04-22
Start date
2008-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral hemorrhage

Interventions

Patients:No
Controls:No

Sponsors

The Fifth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. First-ever intracerebral hemorrhage; 2. Aged >=18 years; 3. Within 1-3 days of onset; 4. Hospitalized.

Exclusion criteria

Exclusion criteria: 1. mixed stroke; 2. hemorrhagic cerebral infarct; 3. comorbidities including malignant/autoimmune disease; severe infection; systemic inflammatory response syndrome (SIRS) with onset within one week of intracerebral hemorrhage; severe dysfunction of the heart, lung, liver, or kidney; 4. Use of immunomodulators; 5. Neurologic impairment or disability caused by trauma or other diseases.

Design outcomes

Primary

MeasureTime frame
Monocyte chemoattractant protein (MCP)-1;Regulated upon activation, normal T cell expressed and secreted (RANTES);—

Countries

China

Contacts

Public ContactZhendong Li
LZD162@tom.com+86 0756 2528725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026